¥1,792.00 ($11.36)

+6.00 (+0.34%)

Weekly Expected Move ±4.2%

¥1635 ¥1710 ¥1786 ¥1862 ¥1937

JPX · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 42 · ¥132.5B mcap · 59M float · 0.410% daily turnover

Revenue

$121.5B +4.6% ▲

5Y CAGR: +7.5%

Gross Profit

$65.1B +6.7% ▲

5Y CAGR: +7.5%

Operating Income

$10.1B +12.3% ▲

5Y CAGR: +7.4%

Net Income

$5.6B +23.9% ▲

5Y CAGR: +6.7%

EPS (Diluted)

$69.13 +25.3% ▲

5Y CAGR: +5.3%

EBITDA

$18.5B +17.7% ▲

5Y CAGR: +9.3%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$86.2B	$100.2B	$110.2B	$116.2B	$121.5B
YoY Growth	+2.0%	+16.2%	+10.0%	+5.4%	+4.6%
Cost of Revenue	$40.4B	$47.3B	$51.7B	$55.2B	$56.4B
Gross Profit	$45.8B	$52.9B	$58.5B	$61.0B	$65.1B
Gross Margin	53.1%	52.8%	53.1%	52.5%	53.6%
R&D Expenses	$3.6B	$3.9B	$4.3B	$5.1B	$5.9B
SG&A Expenses	$34.1B	$39.0B	$42.1B	$46.9B	$55.0B
Operating Expenses	$37.7B	$42.9B	$46.4B	$52.1B	$55.0B
Operating Income	$8.1B	$10.0B	$12.1B	$9.0B	$10.1B
Operating Margin	9.4%	9.9%	10.9%	7.7%	8.3%
Interest Expense	$278M	$332M	$440M	$672M	$751M
Income Before Tax	$8.4B	$9.9B	$11.5B	$7.1B	$9.3B
Tax Expense	$2.4B	$3.4B	$4.1B	$2.6B	$3.7B
Net Income	$6.0B	$6.5B	$7.4B	$4.5B	$5.6B
Net Margin	6.9%	6.5%	6.7%	3.9%	4.6%
EPS (Diluted)	$77.23	$79.06	$89.77	$55.17	$69.13
EBITDA	$14.1B	$17.5B	$19.3B	$15.7B	$18.5B
Shares Outstanding	76M	82M	82M	83M	82M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$30.4B	$30.9B	$30.0B	$30.3B	$31.2B	$32.5B	$31.7B	$32.4B
Cost of Revenue	$14.1B	$14.3B	$14.3B	$14.1B	$14.1B	$14.9B	$14.9B	$14.8B
Gross Profit	$16.3B	$16.6B	$15.6B	$16.1B	$17.2B	$17.6B	$16.7B	$17.6B
Gross Margin	53.5%	53.8%	52.2%	53.2%	55.0%	54.2%	52.8%	54.3%
R&D Expenses	$0	$0	$5.9B	$0	$0	$0	$0	$0
SG&A Expenses	$13.5B	$13.6B	$14.2B	$14.1B	$14.0B	$13.8B	$15.5B	$14.1B
Operating Expenses	$13.5B	$13.6B	$14.2B	$14.1B	$14.0B	$13.8B	$15.5B	$14.1B
Operating Income	$2.8B	$3.1B	$1.5B	$2.0B	$3.2B	$3.8B	$1.2B	$3.4B
Operating Margin	9.2%	10.0%	4.9%	6.5%	10.3%	11.8%	3.9%	10.6%
Interest Expense	$143M	$223M	$225M	$200M	$205M	$206M	$199M	$217M
Income Before Tax	$2.9B	$2.3B	$1.4B	$1.8B	$3.2B	$4.4B	-$569M	$3.4B
Tax Expense	$1.0B	$851M	$904M	$784M	$1.1B	$1.2B	-$136M	$1.1B
Net Income	$1.9B	$1.5B	$507M	$992M	$2.2B	$3.2B	-$433M	$2.2B
Net Margin	6.1%	4.8%	1.7%	3.3%	6.9%	9.8%	-1.4%	6.9%
EPS (Diluted)	$22.56	$18.16	$6.62	$12.99	$28.62	$42.63	$-5.55	$29.89
EBITDA	$5.0B	$6.5B	$2.4B	$4.4B	$5.9B	$6.5B	$4.5B	$6.0B
Shares Outstanding	83M	82M	79M	76M	76M	75M	78M	75M

7780.T JPX